Advanced Search
Contact | Corporate | Help

Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer

Sponsors:
  • Memorial Sloan-Kettering Cancer Center
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Female
Names:
  • Drug: pertuzumab in combination with trastuzumab and paclitaxel
Enrollment:
69

Additional information about NCT01276041.


SourceSolution © 2008-2012